font size
Sign inprintPrint


Study Highlights Opportunities to Reduce Spending on Costly Specialty Drugs

New report says payers could benefit by transitioning specialty medications from the medical to the pharmacy benefit.

Specialty drugs present a challenge for payers as costs for these complex and expensive drugs consume an increasing portion of overall health care spending. In fact, specialty pharmacy spend is expected to rise from $92 billion in 2012 to $235 billion by 2018. And more than half of specialty medication spending currently occurs under the medical benefit of insurance plans. Moving that benefit to a pharmacy benefit can produce significant savings for healthcare payers by improving management of specialty drugs, according to a new report. Read More
Other recent stories

Sign Up to recevie the Burrill Weekly Brief

Follow burrillreport on Twitter